International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

…, M Xu, T Fujita, S Hazama, N Suzuki, H Nagano… - The Lancet, 2018 - thelancet.com
Background The estimation of risk of recurrence for patients with colon carcinoma must be
improved. A robust immune score quantification is needed to introduce immune parameters …

[PDF][PDF] Reprogramming of mouse and human cells to pluripotency using mature microRNAs

N Miyoshi, H Ishii, H Nagano, N Haraguchi, DL Dewi… - Cell stem cell, 2011 - cell.com
Induced pluripotent stem cells (iPSCs) can be generated from differentiated human and mouse
somatic cells using transcription factors such as Oct4, Sox2, Klf4, and c-Myc. It is possible …

[HTML][HTML] CD13 is a therapeutic target in human liver cancer stem cells

…, D Takiuchi, H Hatano, H Nagano… - The Journal of …, 2010 - Am Soc Clin Investig
Cancer stem cells (CSCs) are generally dormant or slowly cycling tumor cells that have the
ability to reconstitute tumors. They are thought to be involved in tumor resistance to chemo/…

Clinical practice guidelines for hepatocellular carcinoma: the Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update

…, S Kubo, M Shimada, H Nagano… - Hepatology …, 2019 - Wiley Online Library
The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised
by the Japan Society of Hepatology, according to the methodology of evidence‐based …

Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma

Y Tomimaru, H Eguchi, H Nagano, H Wada… - Journal of …, 2012 - Elsevier
BACKGROUND & AIMS: Several groups have reported the significance of circulating microRNA
as a biochemical marker of cancer. To our knowledge, however, there are no reports on …

The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma

…, A Hosui, T Tatsumi, H Ishida, T Noda, H Nagano… - Journal of …, 2010 - Elsevier
BACKGROUND & AIMS: Bcl-xL, an anti-apoptotic member of the Bcl-2 family, is over-expressed
in human hepatocellular carcinoma, conferring a survival advantage to tumour cells. …

Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma

…, Y Tomita, Y Hoshida, T Morooka, H Nagano… - Clinical cancer …, 2004 - AACR
Purpose: Akt is a serine/threonine kinase that plays a central role in tumorigenesis. Among
the members of Akt family, Akt2 is associated with the development of human cancers. The …

Defined factors induce reprogramming of gastrointestinal cancer cells

…, K Mimori, F Tanaka, H Nagano… - Proceedings of the …, 2010 - National Acad Sciences
Although cancer is a disease with genetic and epigenetic origins, the possible effects of
reprogramming by defined factors remain to be fully understood. We studied the effects of the …

Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial

…, M Sekimoto, T Ajiki, I Nakamura, I Miki, H Nagano… - The Lancet, 2023 - thelancet.com
Background S-1 has shown promising efficacy with a mild toxicity profile in patients with
advanced biliary tract cancer. The aim of this study was to evaluate whether adjuvant S-1 …

Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice

…, T Kawabata, M Hamasaki, H Eguchi, H Nagano… - Hepatology, 2016 - journals.lww.com
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. It
encompasses a spectrum ranging from simple steatosis to fatty liver with hepatocellular injury, …